Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for Colorectal Cancer SUZHOU, China, Oct. 27, 2025 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK)… CISION PRNewswireOctober 27, 2025
NetDragon and Open University Malaysia Sign Strategic MOU to Jointly Explore New Models of AI-Powered Open Education HONG KONG, Oct. 27, 2025 /PRNewswire/ — NetDragon Websoft Holdings Limited ("NetDragon"… CISION PRNewswireOctober 27, 2025
Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025 SHANGHAI and HONG KONG, Oct. 27, 2025 /PRNewswire/ — Antengene Corporation Limited… CISION PRNewswireOctober 27, 2025
Indigenously Designed and Manufactured Laptops by Vyonix Launched at IMC 2025 GURUGRAM, India, Oct. 27, 2025 /PRNewswire/ — India’s 1st indigenously designed and… CISION PRNewswireOctober 27, 2025
Press Release YeePay Showcases One-Stop Global Payment Solutions at ITB Asia 2025, Empowering the Global Travel Ecosystem SINGAPORE, Oct. 27, 2025 /PRNewswire/ — YeePay, a leading digital transaction service… CISION PRNewswireOctober 27, 2025
Indigenously Designed and Manufactured Laptops by Vyonix Launched at IMC 2025 GURUGRAM, India, Oct. 27, 2025 /PRNewswire/ — India’s 1st indigenously designed and… CISION PRNewswireOctober 27, 2025
Press Release 138th Canton Fair Showcases Practical Aesthetics in Home and Garden Innovation GUANGZHOU, China, Oct. 27, 2025 /PRNewswire/ — At Phase 2 of the… CISION PRNewswireOctober 27, 2025
Innovent's Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3 The proportion of participants achieving HbA1c < 7.0% and a ≥10% reduction… CISION PRNewswireOctober 27, 2025
